Understanding Uveal Melanoma
Author Information
Author(s): Papastefanou Vasilios P., Cohen Victoria M. L.
Primary Institution: Moorfields Eye Hospital, St Bartholomew's Hospital, London, UK
Hypothesis
What are the epidemiologic, pathogenetic, and clinical aspects of uveal melanoma?
Conclusion
Despite advances in local treatments, patient survival rates for uveal melanoma have not improved in three decades.
Supporting Evidence
- Uveal melanoma is the most common primary intraocular malignancy.
- Current survival rates have not changed for three decades despite advances in treatment.
- Development of metastases significantly affects prognosis.
Takeaway
Uveal melanoma is a type of eye cancer that is very serious, and even with new treatments, people are not living longer than they did 30 years ago.
Methodology
The paper discusses epidemiologic, pathogenetic, and clinical aspects of uveal melanoma, including risk factors, diagnosis, and treatment options.
Limitations
The study does not provide new clinical trial data or specific patient outcomes.
Participant Demographics
Uveal melanoma primarily affects adults, with a median age of diagnosis around 55 years, and both sexes are equally affected with a slight predominance of males.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website